✦ LIBER ✦

A dose-dense carboplatin and paclitaxel regimen is highly active in the treatment of recurrent ovarian cancer

✍ Scribed by Hunn, J.; Tenney, M.; Hoekstra, A.; Puglisi, A.; Kirschner, C.; Hurteau, J.; Rodriguez, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The “Leuven” dose-dense paclitaxel/carbo

✍ Isabelle Cadron; Karin Leunen; Frédéric Amant; Toon Van Gorp; Patrick Neven; Ign 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 310 KB

The combination of monthly carboplatin a

✍ Anna V. Hoekstra; Jean A. Hurteau; Carolyn V. Kirschner; Gustavo C. Rodriguez 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Weekly dose-dense paclitaxel and carbopl

✍ Shawky, Hanan; Tawfik, Hesham; Hewidy, Medhat 📂 Article 📅 2014 🏛 National Cancer Institute - Egypt 🌐 English ⚖ 557 KB

Weekly Low-Dose Carboplatin and Paclitax

✍ Laura J. Havrilesky; Angeles A. Alvarez; Robyn A. Sayer; Johnathan M. Lancaster; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Dose-dense cisplatin/paclitaxel: a well-

✍ F.E de Jongh; R de Wit; J Verweij; A Sparreboom; M.J van den Bent; G Stoter; M.E 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

An economic analysis of dose dense weekl

✍ Heather J. Dalton; Xinhua Yu; Lilian Hu; Daniel S. Kapp; Ivor Benjamin; Bradley 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 558 KB